Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Bone Neoplasms × olaparib × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Ovarian Neoplasms 75 Breast Neoplasms 56 Prostatic Neoplasms 29 Triple Negative Breast Neoplasms 23 Fallopian Tube Neoplasms 22 Neoplasms 21 Pancreatic Neoplasms 16 Endometrial Neoplasms 16 Neoplasm Metastasis 15 Small Cell Lung Carcinoma 13 Sarcoma 9 Carcinoma, Ovarian Epithelial 9 Stomach Neoplasms 8 Squamous Cell Carcinoma of Head and Neck 8 Carcinoma, Non-Small-Cell Lung 8 Recurrence 7 Glioma 7 Fanconi Anemia, Complementation Group D1 7 Lung Neoplasms 6 Colorectal Neoplasms 6 Lymphoma, Non-Hodgkin 5 Glioblastoma 5 Cholangiocarcinoma 5 Urinary Bladder Neoplasms 4 Solid Tumors 4 Parkinson Disease 4, Autosomal Dominant Lewy Body 4 Neuroendocrine Tumors 4 Metastatic Castration-resistant Prostate Cancer 4 Carcinoma, Squamous Cell 4 Advanced Solid Tumors 4

Interventions

Ibandronic Acid 8 Gemcitabine 7 Doxorubicin 6 Radiation 4 Irinotecan 4 Cyclophosphamide 4 pembrolizumab 3 Zoledronic Acid 3 Vincristine 3 Temozolomide 3 Nivolumab 3 Magnetic Resonance Spectroscopy 3 Docetaxel 3 3-(5-fluorobenzofuran-3-yl)-4-(5-methyl-5H-(1,3)dioxolo(4,5-f)indol-7-yl)-pyrrole-2,5-dione 3 pegfilgrastim 2 Tranexamic Acid 2 Trabectedin 2 Sunitinib 2 Standard of Care 2 Radiotherapy, Intensity-Modulated 2 Radiotherapy 2 Methotrexate 2 Ipilimumab 2 Injections 2 Ifosfamide 2 Etoposide 2 Denosumab 2 Cryotherapy 2 Cryosurgery 2 Cisplatin 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02398058 2021-04-14

TOMAS

Italian Sarcoma Group

Phase 1 Completed

Bone Neoplasms, Sarcoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡